Endo Int'l (ENDP) Tops Q3 EPS by 16c

Endo Int'l (NASDAQ: ENDP) reported Q3 EPS of $1.15, $0.16 better than the analyst estimate of $0.99. Revenue for the quarter came in at $764 million versus the consensus estimate of $721.11 million.

Endo Int'l sees FY2014 EPS of $4.10-$4.25, versus the consensus of $4.09. Endo Int'l sees FY2014 revenue of $2.80-2.88 billion, versus the consensus of $2.81 billion.

For earnings history and earnings-related data on Endo Int'l (ENDP) click here.

You May Also Be Interested In

• United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance
• Guggenheim Reiterates Buy Rating on Oracle (ORCL)
• Citi upgrades C.H. Robinson to Buy with $185 target, Opens 90-Day upside catalyst watch